본문 바로가기
KERD
논문KCI 등재

치매 및 인지장애에서의 신경심리평가

Neuropsychological Assessment of Dementia and Cognitive Disorders

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류정신과학

초록

Neuropsychological assessment is concerned with the behavioral expression of brain function through a series of cognitive testing tools. These results provide the objective identification of cognitive deficits, and play a key role in the detection of dementia and related cognitive disorders. New diagnostic guidelines for Alzheimer’s disease (AD) and AD biomarker models suggest that cognitive declines are evidence of advanced neurodegenerative disease. Accordingly, the traditional contribution of neuropsychological assessment in early detection and diagnosis has been brought into question. In this review, the utility of neuropsychological assessment concerning dementia and cognitive disorders has been revisited. Neuropsychological assessment still plays a role in differential diagnosis as well as diagnosis. It is also useful to document cognitive changes along the dementia trajectory and to predict progression. Neuropsychological performance can estimate functional status and predict functional changes in everyday life. Identification of cognitive strengths and weaknesses can assist in intervention planning. However, the utility of neuropsychological assessment is not guaranteed if the neuropsychological tests have insufficient reliability, validity, and normative information. Commonly used cognitive screening tests and neuropsychological test batteries were examined. Lastly, several special considerations in the assessment of older adults were discussed.

Abstract

Neuropsychological assessment is concerned with the behavioral expression of brain function through a series of cognitive testing tools. These results provide the objective identification of cognitive deficits, and play a key role in the detection of dementia and related cognitive disorders. New diagnostic guidelines for Alzheimer’s disease (AD) and AD biomarker models suggest that cognitive declines are evidence of advanced neurodegenerative disease. Accordingly, the traditional contribution of neuropsychological assessment in early detection and diagnosis has been brought into question. In this review, the utility of neuropsychological assessment concerning dementia and cognitive disorders has been revisited. Neuropsychological assessment still plays a role in differential diagnosis as well as diagnosis. It is also useful to document cognitive changes along the dementia trajectory and to predict progression. Neuropsychological performance can estimate functional status and predict functional changes in everyday life. Identification of cognitive strengths and weaknesses can assist in intervention planning. However, the utility of neuropsychological assessment is not guaranteed if the neuropsychological tests have insufficient reliability, validity, and normative information. Commonly used cognitive screening tests and neuropsychological test batteries were examined. Lastly, several special considerations in the assessment of older adults were discussed.

참고문헌 (73)

  1. Lezak MD, "Neuropsychological assessment" (2012), Oxford University Press
  2. Hampel H, "Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives", Nat Rev Drug Discov, 9, pp.560~574 (2010)
  3. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
  4. Jack CR Jr, "Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.257~262 (2011)
  5. McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.263~269 (2011)
  6. Sperling RA, "Toward defining the preclinical stages of Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.280~292 (2011)
  7. 이동영, "새로운 알츠하이머병 임상진단기준 : NIA-AA 진단가이드라인을 중심으로", 노인정신의학, 16(1), pp.7~12 (2012), 대한노인정신의학회[DOI]
  8. Stuss DT, "Principles of frontal lobe function" (2013), Oxford University Press
  9. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders (DSM-5®)" (2013), American Psychiatric Association Pub
  10. Braak H, "Neuropathological stageing of Alzheimer-related changes", Acta Neuropathol, 82, pp.239~259 (1991)
  11. Salmon DP, "Neuropsychological assessment of dementia", Annu Rev Psychol, 60, pp.257~282 (2009)
  12. Salmon DP, "Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals", Neurology, 59, pp.1022~1028 (2002)
  13. Desmond DW, "The neuropsychology of vascular cognitive impairment : is there a specific cognitive deficit?", J Neurol Sci, 226, pp.3~7 (2004)
  14. Reed BR, "Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease", Brain, 130(Pt 3), pp.731~739 (2007)
  15. Marui W, "Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease", Acta Neuropathol, 108, pp.121~128 (2004)
  16. Rascovsky K, "Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer’s disease", Neuropsychology, 21, pp.20~30 (2007)
  17. Karantzoulis S, "Distinguishing Alzheimer’s disease from other major forms of dementia", Expert Rev Neurother, 11, pp.1579~1591 (2011)
  18. Fields JA, "Neuropsychological assessment of patients with dementing illness", Nat Rev Neurol, 7, pp.677~687 (2011)
  19. Smith GE, "plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?", Neurology, 69, pp.133~139 (2007)
  20. Grady CL, "Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer’s disease", J Neurosci, 23, pp.986~993 (2003)
  21. Bilgel M, "Temporal order of Alzheimer’s disease-related cognitive marker changes in BLSA and WRAP longitudinal studies", J Alzheimers Dis, 59, pp.1335~1347 (2017)
  22. Seo EH, "Altered executive function in premild cognitive impairment", J Alzheimers Dis, 54, pp.933~940 (2016)
  23. Gallucci M, "Neuropsychological tools to predict conversion from amnestic mild cognitive impairment to dementia. The TREDEM Registry", Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, pp.1~11 (2017)
  24. Li K, "Alzheimer’s Disease Neuroimaging Initiative. Prediction of conversion to Alzheimer’s disease with longitudinal measures and time-to-event data", J Alzheimers Dis, 58, pp.361~371 (2017)
  25. Clark DG, "Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment", Alzheimers Dement(Amst), 2, pp.113~122 (2016)
  26. Mazzeo S, "Combining cerebrospinal fluid biomarkers and neuropsychological assessment : a simple and cost-effective algorithm to predict the progression from mild cognitive impairment to Alzheimer’s disease dementia", J Alzheimers Dis, 54, pp.1495~1508 (2016)
  27. Jang H, "Prediction model of conversion to dementia risk in subjects with amnestic mild cognitive impairment: a longitudinal, multi-center clinic-based study", J Alzheimers Dis, 60, pp.1579~1587 (2017)
  28. Blacker D, "Neuropsychological measures in normal individuals that predict subsequent cognitive decline", Arch Neurol, 64, pp.862~871 (2007)
  29. Oulhaj A, "Predicting the time of conversion to MCI in the elderly : role of verbal expression and learning", Neurology, 73, pp.1436~1442 (2009)
  30. Chen Y, "Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort", Alzheimers Dement, 13, pp.399~405 (2017)
  31. Schmitter-Edgecombe M, "Cognitive correlates of functional performance in older adults: comparison of self-report, direct observation, and performance-based measures", J Int Neuropsychol Soc, 17, pp.853~864 (2011)
  32. Fields JA, "Utility of the DRS for predicting problems in day-to-day functioning", Clin Neuropsychol, 24, pp.1167~1180 (2010)
  33. Biomarkers Definitions Working Group, "Biomarkers and surrogate endpoints : preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)
  34. Ritchie K, "Recommended cognitive outcomes in preclinical Alzheimer’s disease : consensus statement from the European Prevention of Alzheimer’s Dementia project", Alzheimers Dement, 13, pp.186~195 (2017)
  35. Weintraub S, "Is cognitive decline measurable in preclinical Alzheimer’s disease?", Alzheimers Dement, 13, pp.322~323 (2017)
  36. Weston PSJ, "Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer’s disease : a cross-sectional study", Lancet Neurol, 17, pp.123~132 (2018)
  37. American Educational Research Association, American Psychological Association, National Council on Measurment in Education, "Joint Committee on Standards for Educational and Psychological Testing. Standards for educational and psychological testing", Amer Educational Research Assn, ~ (2014)
  38. Stein J, "The assessment of changes in cognitive functioning : reliable change indices for neuropsychological instruments in the elderly-a systematic review", Dement Geriatr Cogn Disord, 29, pp.275~286 (2010)
  39. Stuart-Hamilton I, "The Psychology of Ageing" (2017), Seoul National University Press
  40. Strauss E, "A compendium of neuropsychological tests: administration, norms, and commentary" (2006), Oxford University Press
  41. O’Connell ME, "Age corrections and dementia classification accuracy", Arch Clin Neuropsychol, 25, pp.126~138 (2010)
  42. Chey J, "Effects of education in dementia assessment : evidence from standardizing the Korean-Dementia Rating Scale", Clin Neuropsychol, 13, pp.293~302 (1999)
  43. Lee JH, "Development of the Korean version of the consortium to establish a registry for Alzheimer’s disease assessment packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.47~53 (2002)
  44. Kang Y, "Seoul neuropsychological screening battery" (2003), Human Brain Research & Consulting Co.
  45. Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly", J Int Neuropsychol Soc, 10, pp.72~81 (2004)
  46. 안현정, "Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients", Journal of Korean Medical Science, 25(7), pp.1071~1076 (2010), 대한의학회
  47. Seo EH, "A normative study of the Trail Making Test in Korean elders", Int J Geriatr Psychiatry, 21, pp.844~852 (2006)
  48. Folstein MF, ""Mini-mental state" : a practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
  49. Park JH, "Korean version of Mini-Mental State Examination (MMSE-K). Part I: development of the test for the elderly", J Korean Neuropsychiatr Assoc, 28, pp.125~135 (1989)
  50. Kang YW, "A validity study on the korean mini-mental state examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
  51. 이동영, "Mini-Mental State Examination의 한국 노인 정상규준 연구", 신경정신의학, 41(3), pp.508~525 (2002), 대한신경정신의학회
  52. Tae Hui Kim, "Korean Version of Mini Mental Status Examination for Dementia Screening and Its Short Form", PSYCHIATRY INVESTIGATION, 7(2), pp.102~108 (2010), 대한신경정신의학회
  53. Johnson JK, "Executive function, more than global cognition, predicts functional decline and mortality in elderly women", J Gerontol A Biol Sci Med Sci, 62, pp.1134~1141 (2007)
  54. Wouters H, "Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG", Int J Geriatr Psychiatry, 25, pp.770~779 (2010)
  55. In-Woong Kang, "Accuracy of Korean-Mini-Mental Status Examination Based on Seoul Neuro-Psychological Screening Battery II Results", Korean Journal of Family Medicine, 37(3), pp.177~181 (2016), 대한가정의학회
  56. Teng EL, "The Modified Mini-Mental State(3MS)examination", J Clin Psychiatry, 48, pp.314~318 (1987)
  57. 손은희, "한국판 Modified Mini-Mental State (K-3MS) Examination의 타당도", 대한신경과학회지, 21(4), pp.4~356 (2003), 대한신경과학회
  58. Nasreddine ZS, "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment", J Am Geriatr Soc, 53, pp.695~699 (2005)
  59. 강연욱, "혈관성 인지장애 선별검사로서 Korean-Montreal Cognitive Assessment(K-MoCA)의 신뢰도, 타당도 및 규준 연구", Korean Journal of Clinical Psychology, 28(2), pp.549~562 (2009), 한국임상심리학회[DOI]
  60. Lee JY, "Brief screening for mild cognitive impairment in elderly outpatient clinic : validation of the Korean version of the Montreal Cognitive Assessment", J Geriatr Psychiatry Neurol, 21, pp.104~110 (2008)
  61. Gluhm S, "Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan", Cogn Behav Neurol, 26, pp.1~5 (2013)
  62. Woo JI, "The Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K)" (2015), Seoul National University Press
  63. Seo EH, "Total scores of the CERAD neuropsychological assessment battery : validation for mild cognitive impairment and dementia patients with diverse etiologies", Am J Geriatr Psychiatry, 18, pp.801~809 (2010)
  64. Kang Y, "Seoul neuropsychological screening battery" (2012), Human Brain Research & Consulting Co
  65. 장승민, "Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core", Dementia and Neurocognitive Disorders(대한치매학회지), 14(4), pp.137~142 (2015), 대한치매학회[DOI]
  66. Mattis S., "Dementia Rating Scale: professional manual" (1988), Psychological Assessment Resources
  67. 석정서, "한국판 치매 평가 검사(K-DRS)의 2차 규준 연구", Korean Journal of Clinical Psychology, 29(2), pp.559~572 (2010), 한국임상심리학회[DOI]
  68. Rosen WG, "A new rating scale for Alzheimer’s disease", Am J Psychiatry, 141, pp.1356~1364 (1984)
  69. Cano SJ, "The ADAS-cog in Alzheimer’s disease clinical trials : psychometric evaluation of the sum and its parts", J Neurol Neurosurg Psychiatry, 81, pp.1363~1368 (2010)
  70. Youn JC, "Development of the Korean version of Alzheimer’s Disease Assessment Scale(ADAS-K)", Int J Geriatr Psychiatry, 17, pp.797~803 (2002)
  71. Nelson HE, "Dementia : the estimation of premorbid intelligence levels using the new adult reading test", Cortex, 14, pp.234~244 (1978)
  72. Yi D, "Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients", PLoS One, 12, pp.e0181523~ (2017)
  73. Holden UP., "Neuropsychology and aging: definitions, explanations, and practical approaches" (1988), New York University Press

관련 논문AI추천

이 간행물의 다른 논문 (8건)